Margitta Worm

1. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
   2020/10/01 by A. Wollenberg, Andreas Wollenberg, A. Blauvelt +39 · 36 citations
   Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Allergic Rhinitis and Sensitization #Psoriasis: Treatment and Pathogenesis
2. EAACI guidelines: Anaphylaxis (2021 update)
   2021/08/03 by Antonella Muraro, Margitta Worm, Cherry Alviani +29 · 2 citations
   Medicine · #Asthma and respiratory diseases #Eosinophilic Esophagitis #Food Allergy and Anaphylaxis Research
3. EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
   2014/06/09 by A. Muraro, Antonella Muraro, T. Werfel +68 · 1 citation
   Medicine · #Asthma and respiratory diseases #Eosinophilic Esophagitis #Food Allergy and Anaphylaxis Research